Indo Borax & Chemicals Limited has informed the Exchange regarding appointment/re-appointment of Internal Auditor and Cost Auditor for the financial year 2026-27.
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 15.8 pts more than Nifty Microcap 250 and 17.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo Borax & Chemicals Limited reported strong FY2025-26 results with standalone revenue from operations growing 23% to Rs. 21,545 Lakhs from Rs. 17,526 Lakhs. PAT grew 18.8% to Rs. 4,974 Lakhs vs Rs. 4,188 Lakhs. The Board declared a final dividend of Rs. 10 per share (1000%) and a special dividend of Rs. 30 per share (3000%), subject to shareholder approval. Appointment details: M/s. Shah Kapadia & Associates appointed as Internal Auditor for FY 2026-27; M/s. V. B. Modi & Associates re-appointed as Cost Auditor for FY 2026-27. The auditors issued an unmodified (clean) opinion. However, an Emphasis of Matter paragraph highlights an inter-corporate deposit of Rs. 5.09 Crs given to a party that has filed for corporate insolvency under IBC, and the company has filed its claim as financial creditor awaiting NCLT decision. An exceptional item of Rs. 1,014.75 Lakhs was recorded (likely from property disposal).
Strong revenue and profit growth with 4000% total dividend payout signals confidence, but the Emphasis of Matter regarding the Rs. 5.09 Crs inter-corporate deposit in insolvency raises concern about potential bad debt provisioning risk.